Principal Display Panel (50 mg Tablet Bottle Label)
Vimpat
Product Images NDC 54868-6077
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vimpat (NDC 54868-6077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Vimpat 01)
Figure (Vimpat 02)
Figure 1 shows the median percent reduction in seizure frequency per 28 days from baseline to the maintenance phase by dose, for three different studies. The graph indicates the percentage of reduction in seizure frequency for each study at different doses. The text also notes statistically significant differences when compared to a placebo.*
Figure (Vimpat 03)
This is a chart presenting the responder rate, improvement, and worsening for patients using VIMPAT and a placebo in studies 1, 2, and 3. The chart displays the proportion of patients in percentages and two VIMPAT dosage groups, 200mg/day and 400mg/day. The responder rate is not defined, and the chart does not provide any information regarding the condition being treated or the outcomes measured.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
